Article
Single-cell profiling of gastric cancer ascites reveals an epithelial-immune dual phenotype signature predictive for anti-PD-1 immunotherapy responses.
BMC medicine - 29 Jun 2026
Xu Tianbing, Yang Muyang, Huang Jing, Lu Lisen, Deng Deqiang, Shi Xiujuan, Sun Yao, Lovell Jonathan F, Lin Zhenyu, Zheng Yongfa, Jin Honglin
Abstract excerpt
BACKGROUND: Gastric cancer (GC) with peritoneal metastasis frequently leads to malignant ascites (MA), a highly immunosuppressive "liquid tumor microenvironment" associated with poor prognosis. Although immune checkpoint blockade (ICB) demonstrate efficacy in some GC patients, treatment response to gastric cancer-associated peritoneal metastasis (GCPM) remains heterogeneous. The immune mechanisms driving this...
Read the complete abstract on PubMedTopics
- Humans
- Stomach Neoplasms
- Ascites
- Single-Cell Analysis
- Immunotherapy
- Programmed Cell Death 1 Receptor
